Category: Wall Street Beat
Allergan is still looking to prevent Valeant Pharmaceuticals and Pershing Square from voting their shares in a December 18 shareholder meeting the company was forced to host.
The $2.14 billion acquisition of Nobel Biocare will turn Danaher into the largest dental implants provider in the world.
A 2nd suitor for orthopedic device maker Biomet ceded the field early to Zimmer, regulatory filings show, but Biomet held out for better terms from its cross-town rival.
ReWalk Robotics prices its initial public offering at $12 a share, under its prior range, raising $36 million for its exoskeleton for spinal cord injury patients
ReWalk Robotics (NSDQ:RWLK) priced its initial public offering below its forecast range, at $12 per share, grossing some $36.0 million for its exo-skeleton suit.
Mevion Medical looks to go public with a $69 million stock offering as it gears up to scale its proton therapy device.
Mevion Medical registered for a $69 million initial public offering as it gears up to commercialize its proton therapy system.
Halyard Health, the publicly traded, $1.6 billion spinout of Kimberly-Clark's medical device business, is slated to go live in November, soon-to-be COO Chris Lowery tells MassDevice.com.
InVivo Therapeutics ex-CEO Frank Reynolds has been liquidating his position in the company, putting even more weight on NVIV's already-pressured shares.
As if InVivo Therapeutics (OTC:NVIV) wasn't having a tough enough time already, the company's stock is under even more pressure as former CEO Frank Reynolds has been liquidating his position over the last few weeks.